| Literature DB >> 26637467 |
Adiljan Kader1, Yan Li2, Kunzhe Dong1, David M Irwin3, Qianjun Zhao1, Xiaohong He1, Jianfeng Liu4, Yabin Pu1, Neena Amatya Gorkhali1, Xuexue Liu1, Lin Jiang1, Xiangchen Li1, Weijun Guan1, Yaping Zhang2, Dong-Dong Wu5, Yuehui Ma6.
Abstract
Body size, one of the most important quantitative traits under evolutionary scrutiny, varies considerably among species and among populations within species. Revealing the genetic basis underlying this variation is very important, particularly in humans where there is a close relationship with diseases and in domestic animals as the selective patterns are associated with improvements in production traits. The Debao pony is a horse breed with small body size that is unique to China; however, it is unknown whether the size-related candidate genes identified in Western breeds also account for the small body size of the Debao pony. Here, we compared individual horses from the Debao population with other two Chinese horse populations using single nucleotide polymorphisms (SNPs) identified with the Equine SNP 65 Bead Chip. The previously reported size-related candidate gene HMGA2 showed a significant signature for selection, consistent with its role observed in human populations. More interestingly, we found a candidate gene TBX3, which had not been observed in previous studies on horse body size that displayed the highest differentiation and most significant association, and thus likely is the dominating factor for the small stature of the Debao pony. Further comparison between the Debao pony and other breeds of horses from around the world demonstrated that TBX3 was selected independently in the Debao pony, suggesting that there were multiple origins of small stature in the horse.Entities:
Keywords: TBX3; XP-EHH; association; di; genetic differentiation; selective signature
Mesh:
Substances:
Year: 2015 PMID: 26637467 PMCID: PMC4758242 DOI: 10.1093/gbe/evv245
Source DB: PubMed Journal: Genome Biol Evol ISSN: 1759-6653 Impact factor: 3.416
FPhylogenetic analysis of horse breeds. (A) Height of the three breeds: DB, MG, and YL. Data were retrieved from China National Commission of Animal Genetic Resources (2011). (B) Phylogenetic tree constructed by TreeMix with bootstrap analysis with the Przewalski’s horse as the outgroup. Red branches are “Arab group.” Names labeled in blue are short stature horses/pony, and green are tall horses. (C) Decay of LD among 35 breeds of horses. (D) Population structure analysis among the 35 breeds. Red arrow signs Przewalski’s horse. (E, F) Multidimensional clustering. Each letter represents a breed. A, Akhal; B, Andalusian; C, Arabian; D, Belgian; E, Caspian; F, Clydesdale; G, Debao; H, Exmoor; I, Fell pony; J, Finnhorse; K, Franches-Montagnes; L, French Trotter; M, Hanoverian; N, Icelandic; O, Inner Mongolian; P, MangalargaPaulista; Q, Miniature; R, Mongolian; S, Morgan; T, New Forest Pony; U, North Swedish Horse; V, Norwegian Fjord; W, Paint; X, Percheron; Y, Peruvian Paso; Z, Puerto Rican Paso Fino; a, Quarter Horse; b, Saddlebred; d: Shetland; e, Shire; f, Standardbred; g, Swiss Warmblood; h, Thoroughbred; i, Tuva; j, Yili. The abbreviation “hh” stands for “hands high.” One hand is equal to 4 inches or 10.16 cm.
FPositive selection analysis of the DB. Genome-wide distribution of (A) di, (B) the P values of the merged XP-EHH values, (C) and Manhattan plot presenting the association P value across the genome in the DB.
Overrepresented GO Categories among Genes Showing High di Value in DB
| Term ID | Description | Gene Number | |
|---|---|---|---|
| GO:0009653 | Anatomical structure morphogenesis | 2.36E-05 | 57 |
| GO:0009888 | Tissue development | 4.33E-05 | 42 |
| GO:0007275 | Multicellular organismal development | 5.62E-05 | 82 |
| GO:0030902 | Hindbrain development | 5.80E-05 | 11 |
| GO:0009790 | Embryo development | 6.85E-05 | 35 |
| GO:0048856 | Anatomical structure development | 7.07E-05 | 87 |
| GO:0044767 | Single-organism developmental process | 1.29E-04 | 90 |
| GO:0032502 | Developmental process | 1.53E-04 | 90 |
| GO:0043009 | Chordate embryonic development | 1.89E-04 | 26 |
| GO:0009792 | Embryo development ending in birth or egg hatching | 2.23E-04 | 26 |
| GO:0002062 | Chondrocyte differentiation | 2.51E-04 | 9 |
| GO:0048731 | System development | 3.29E-04 | 74 |
| GO:0048513 | Organ development | 6.02E-04 | 60 |
| GO:0072089 | Stem cell proliferation | 1.12E-03 | 10 |
| GO:0035107 | Appendage morphogenesis | 1.35E-03 | 11 |
| GO:0035108 | Limb morphogenesis | 1.35E-03 | 11 |
| GO:0061448 | Connective tissue development | 2.07E-03 | 12 |
| GO:0048736 | Appendage development | 2.64E-03 | 11 |
| GO:0060173 | Limb development | 2.64E-03 | 11 |
| GO:0001944 | Vasculature development | 2.72E-03 | 20 |
| GO:0001501 | Skeletal system development | 2.91E-03 | 17 |
| GO:0072359 | Circulatory system development | 4.14E-03 | 26 |
| GO:0072358 | Cardiovascular system development | 4.14E-03 | 26 |
| GO:0001701 | In utero embryonic development | 4.93E-03 | 17 |
| GO:0007417 | Central nervous system development | 5.05E-03 | 22 |
| GO:0061061 | Muscle structure development | 5.08E-03 | 18 |
| GO:0006029 | Proteoglycan metabolic process | 6.30E-03 | 6 |
| GO:0048468 | Cell development | 7.98E-03 | 38 |
| GO:0051216 | Cartilage development | 9.05E-03 | 10 |
| GO:0007420 | Brain development | 9.85E-03 | 18 |
| GO:0048568 | Embryonic organ development | 1.03E-02 | 17 |
| GO:0072091 | Regulation of stem cell proliferation | 1.04E-02 | 7 |
| GO:0009887 | Organ morphogenesis | 1.13E-02 | 26 |
| GO:2000648 | Positive regulation of stem cell proliferation | 1.30E-02 | 6 |
| GO:0048010 | Vascular endothelial growth factor receptor signaling pathway | 1.44E-02 | 5 |
| GO:0001568 | Blood vessel development | 1.47E-02 | 18 |
| GO:0060021 | Palate development | 1.49E-02 | 7 |
| GO:0007605 | Sensory perception of sound | 1.84E-02 | 8 |
| GO:0010629 | Negative regulation of gene expression | 1.85E-02 | 27 |
| GO:0051301 | Cell division | 1.89E-02 | 17 |
| GO:1902679 | Negative regulation of RNA biosynthetic process | 2.08E-02 | 25 |
| GO:0035295 | Tube development | 2.16E-02 | 18 |
| GO:0021549 | Cerebellum development | 2.43E-02 | 6 |
| GO:0048729 | Tissue morphogenesis | 2.47E-02 | 19 |
| GO:0014706 | Striated muscle tissue development | 2.52E-02 | 13 |
| GO:0048598 | Embryonic morphogenesis | 3.21E-02 | 19 |
| GO:0051253 | Negative regulation of RNA metabolic process | 3.25E-02 | 25 |
| GO:0048869 | Cellular developmental process | 3.26E-02 | 58 |
| GO:0007399 | Nervous system development | 3.32E-02 | 35 |
| GO:0050954 | Sensory perception of mechanical stimulus | 3.33E-02 | 8 |
| GO:0030154 | Cell differentiation | 3.38E-02 | 54 |
| GO:0007049 | Cell cycle | 3.50E-02 | 28 |
| GO:0007588 | Excretion | 3.60E-02 | 4 |
| GO:2000113 | Negative regulation of cellular macromolecule biosynthetic process | 3.94E-02 | 26 |
| GO:0002009 | Morphogenesis of an epithelium | 4.04E-02 | 16 |
| GO:0001570 | Vasculogenesis | 4.22E-02 | 6 |
| GO:0060537 | Muscle tissue development | 4.37E-02 | 13 |
| GO:0016486 | Peptide hormone processing | 4.54E-02 | 3 |